Knockdown of GRHL3 Inhibits Activities and Induces Cell Cycle Arrest and Apoptosis of Human Colorectal Cancer Cells

The Grainyhead-like 3(GRHL3) is involved in epidermal barrier formation, neural tube closure and wound repair. Previous studies have suggested that GRHL3 has been linked to many different types of cancers. However, to date, its effects on human colorectal cancer(CRC) has not been clarified yet. Our...

Full description

Saved in:
Bibliographic Details
Published inCurrent medical science Vol. 37; no. 6; pp. 880 - 885
Main Author 王小康;周芬芳;陶浩冉;王昕;张弛;苏飞;王诗培;徐利华;潘雪凯;冯茂辉;谢伟
Format Journal Article
LanguageEnglish
Published Wuhan Huazhong University of Science and Technology 01.12.2017
Department of Oncology,Zhongnan Hospital of Wuhan University,Wuhan 430071,China%School of Clinical Medicine,Fenyang Medical College,Shanxi Medical University,Fenyang 032200,China%Department of General Surgery,Tongshan Renmin Hospital,Tongshan 437400,China
Subjects
Online AccessGet full text
ISSN1672-0733
2096-5230
1993-1352
1993-1352
2523-899X
DOI10.1007/s11596-017-1821-x

Cover

More Information
Summary:The Grainyhead-like 3(GRHL3) is involved in epidermal barrier formation, neural tube closure and wound repair. Previous studies have suggested that GRHL3 has been linked to many different types of cancers. However, to date, its effects on human colorectal cancer(CRC) has not been clarified yet. Our microarray analysis has indicated predominant GRHL3 expression in CRC. The purpose of this study was to investigate the expression and significance of GRHL3 in CRC tumorigenesis using CRC tissues and paired paracancerous tissues, as well as using distinct CRC cell lines(HT29 and DLD1). We observed increased GRHL3 expression at both m RNA and protein levels in CRC tissues and CRC cell lines using quantitative real-time polymerase chain reaction(q RT-PCR) and Western blotting. Moreover, silencing GRHL3 with si RNA could suppress CRC cell proliferation, viability and migration in vitro. We also found that knockdown of GRHL3 could promote cell cycle arrest at G0/G1 phase in HT29 cells and DLD1 cells, and induce cell apoptosis in HT29 cells. Together, our study revealed the down-regulation of GRHL3 in vitro could inhibit CRC cell activity and trigger cell cycle arrest at G0/G1 phase and apoptosis.
Bibliography:The Grainyhead-like 3(GRHL3) is involved in epidermal barrier formation, neural tube closure and wound repair. Previous studies have suggested that GRHL3 has been linked to many different types of cancers. However, to date, its effects on human colorectal cancer(CRC) has not been clarified yet. Our microarray analysis has indicated predominant GRHL3 expression in CRC. The purpose of this study was to investigate the expression and significance of GRHL3 in CRC tumorigenesis using CRC tissues and paired paracancerous tissues, as well as using distinct CRC cell lines(HT29 and DLD1). We observed increased GRHL3 expression at both m RNA and protein levels in CRC tissues and CRC cell lines using quantitative real-time polymerase chain reaction(q RT-PCR) and Western blotting. Moreover, silencing GRHL3 with si RNA could suppress CRC cell proliferation, viability and migration in vitro. We also found that knockdown of GRHL3 could promote cell cycle arrest at G0/G1 phase in HT29 cells and DLD1 cells, and induce cell apoptosis in HT29 cells. Together, our study revealed the down-regulation of GRHL3 in vitro could inhibit CRC cell activity and trigger cell cycle arrest at G0/G1 phase and apoptosis.
Grainyhead-like 3 colorectal cancer proliferation migration cell cycle apoptosis
42-1679/R
Xiao-kang WANG , Fen-fang ZHOU , Hao-ran TAO Xin WANG , Chi ZHANG, Fei SU, Shi-pei WANG , Li-hua XU , Xue-kai PAN 1, Mao-hui FENG , Wei XIE (1Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 2School of Clinical Medicine, Fenyang Medical College, Shanxi Medical University, Fenyang 032200, China 3Department of General Surgery, Tongshan Renmin Hospital, Tongshan 437400, China)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1672-0733
2096-5230
1993-1352
1993-1352
2523-899X
DOI:10.1007/s11596-017-1821-x